Senate panel to hear from pharmacy middlemen on drug prices

The Hill

21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major pharmacy benefit managers to testify next month about the high costs of prescription drugs.

Committee Chairman Chuck Grassley (R-Iowa) and ranking member Ron Wyden (D-Ore.) said executives from Cigna, CVS, Humana, OptumRx and Prime Therapeutics have agreed to appear on April 9.

The hearing will be the third time the Finance Committee has heard about drug prices.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder